Optive UD Allergan eye drops smooth eyes, reduce symptoms of dry eye (30 tubes x 0.4ml)
Dosage form Small eye solution
Specifications Box X 0.4ml
Ingredient Carboxymethylcellulose sodium (Medium Viscussity), carboxylcellulose sodium (high viscosition), glycerin
Indication Eye fatigue, dry eyes, blurred vision
Ingredient
Thành phần cho 1ml
| Composition information | Content |
| Carboxymethylcellulose sodium (Medium Viscussity) | 3.25mg |
| Carboxxethylcellulose sodium (high viscussity) | 1.75mg |
| Glycerin | 9mg |
Uses
Indications
Optive UD drug is indicated in the following cases:
pharmacokinetics
No pharmacological research has been conducted.
Before taking Optive UD Allergan eye drops smooth eyes, reduce symptoms of dry eye (30 tubes x 0.4ml)
How to use
Optive UD drugs are used directly into the eyes.
Dosage
Small 1 or 2 drops into the eye when needed.
Use after eye surgery to follow the doctor's instructions.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when using overdose? There is no possibility of toxic side effects when overdiving systemic.
glycerin is a small molecule found in the body as a natural metabolic compound. Body poisoning from overdose does not occur when using Optive UD. There is no possibility of toxic side effects when overdiving systemic.
What to do when forgetting a dose?
Side Effects
When using Optive UD, you may experience unwanted effects (ADR).
Sore, burning, irritation or itching, eye pain, itchy eye, eyelid red rash, excessive watery, abnormal eye secretion, red eye redness, reducing the sharpness of vision, blurred vision, sensitivity to light and dry eyes (lack of effect).
After -sales experience: The following additional side effects have been determined during the use of after -sales Optive in clinical practice. Because after -sales report on these reactions is voluntary and from a group of unknown scale population, it is not always possible to always be reliable about the frequency of these reactions:
Instructions on how to handle ADR
Notify the doctor with unwanted effects when using the drug.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Optive UD drugs are contraindicated in the following cases:
Precautions when using
only external use.
To avoid contamination, do not let the tip of the drug touch any surface, and avoid direct contact with the eyes.
Throw away the remaining solution in the medication tube after use.
Do not use if the pipe is damaged.
Do not use if the solution is discolored or opaque.
To be out of reach of children.
No expiry date used on the product.
Stop using Optive UD and consult your doctor if the eye is painful, vision change, the eye continues to be red or irritated, or if the eye condition is worse or pulling the radio for more than 72 hours.
Read the instructions carefully before use. If you need more information, please consult your doctor.
The ability to drive and operate machinery
Optive UD can cause temporary blurring or visual disorders after use. Therefore, do not drive or operate machinery until the vision returns to normal.
Pregnancy
There is no data on the use of Optive UD during pregnancy and breastfeeding in humans. However, animal studies do not show any harmful effects when using carboxymethylcellulose during pregnancy. Animal studies do not show teratogenic effects when using glycerin.
Breastfeeding period
Optive UD has not been studied in nursing women. However, Optive UD does not absorb the whole body, therefore, do not excrete through breast milk.
Medicinal interaction
Eye medications used simultaneously should use the Optive UD test at least 5 minutes to avoid the drug being washed away.
Storage
Store at temperatures below 30 ° C.
Other drugs
- ACECLOFENAC 100MG FILM-COATED TABLETS
- BETAHISTINE 16 MG TABLETS
- MOVICOL
- NEBILET 5MG TABLETS
- NATRILIX SR 1.5MG TABLETS
- WINTOGENO CREAM
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions